Mind Medicine (MindMed) Inc. (MNMD)
|52 Week Range||2.12-19.95|
|1y Target Est||-|
|DCF Unlevered||MNMD DCF ->|
|DCF Levered||MNMD LDCF ->|
|Debt / Equity||12.64%||Neutral|
Upgrades & Downgrades
Latest MNMD news
The 7 Most Promising Psychedelic Stocks to Buy in February
5 February 2023
Psychedelic stocks have seen remarkable progress in recent years, evolving from a fad to mainstream medicine. Several pharmaceutical companies are now investigating their potential therapeutic value.
Psychedelic Sunday: Competitive Strategies
15 January 2023
Stephen Tobin on investing in psychedelic stocks while they're still pre-revenue. Will first-movers get the advantage?
Scrutinizing Psychedelic Stocks
8 January 2023
What makes a psychedelic company compelling? Analyst Alex Carchidi has a background in biotech and focuses on long-term growth and risk management.
3 Biotech Stocks Aiming to Reinvent Mental Health Treatment
6 December 2022
Atai, Biogen, and Sage are working to develop new treatments for mental illness.
MindMed price target lowered by Canaccord analysts after Phase 2a US clinical trial shelved
21 November 2022
Mind Medicine (MindMed (NASDAQ:MNMD, NEO:MMED)) Inc has earned a repeat ‘Speculative Buy' rating with a lowered price target of US$18 from US$22 per share from Canaccord Genuity (TSX:CF, LSE:CF) analy...
Mind Medicine (MindMed), Inc. (MNMD) Q3 2022 Earnings Call Transcript
10 November 2022
Mind Medicine (MindMed), Inc. (NASDAQ:MNMD ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Robert Barrow - CEO & Director Schond Greenway - CFO Daniel Karlin - Chi...
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
28 October 2022
Risk is part of investing. Even the most mature, well-established firms and stocks run the risk of declining to zero.
Mind Medicine (MNMD) to Report Q3 Earnings: What's in Store?
26 October 2022
Mind Medicine MindMed (MNMD) is expected to provide an update on its pipeline candidates in its third-quarter earnings.
10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022
19 October 2022
Penny stocks to buy according to analysts in 2022. The post 10 Top Penny Stocks To Buy According To Wall Street Analysts In 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | Pe...
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >